ERYTHROPLAKIA
Clinical trials for ERYTHROPLAKIA explained in plain language.
Never miss a new study
Get alerted when new ERYTHROPLAKIA trials appear
Sign up with your email to follow new studies for ERYTHROPLAKIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Glow-in-the-Dark mouth scans could catch cancer early
Diagnosis OngoingThis study tests whether special lights and cameras can help find early signs of mouth cancer in people at high risk. About 338 participants with mouth lesions or conditions like Fanconi anemia will have their mouths examined with fluorescence imaging and tissue sampling. The goa…
Matched conditions: ERYTHROPLAKIA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated May 17, 2026 04:43 UTC
-
Could a common diabetes drug stop oral cancer before it starts?
Prevention OngoingThis study tests whether metformin, a drug used for diabetes, can prevent oral cancer in people with precancerous mouth lesions (leukoplakia or erythroplakia). About 26 participants took metformin to see if their lesions shrank or disappeared. The goal is to find a simple way to …
Matched conditions: ERYTHROPLAKIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 17, 2026 04:50 UTC
-
Could a common diabetes drug stop oral cancer before it starts?
Prevention OngoingThis study tests whether metformin, a common diabetes drug, can prevent oral cancer in 34 people with precancerous white or red patches in the mouth. Participants take metformin to see if it can reverse or stop these patches from turning into cancer. The goal is to find a safe, l…
Matched conditions: ERYTHROPLAKIA
Phase: PHASE2 • Sponsor: University of Arizona • Aim: Prevention
Last updated May 17, 2026 04:49 UTC